FDA MedWatch

Defective components may cause affected devices to not deliver electric shocks, and the device's self-test may not detect the defect in advance of use.

Product found containing the bacteria B. cepacia.

Recall of product, sold as a dietary supplement, containing undeclared sulfoaildenafil.

Nationwide recall due to stretching or fracture of the sheath during use.

Five products marketed as dietary supplements contain undeclared substances considered to be steroids.

Effectiveness of clopidogrel is reduced when taken with omeprazole, placing patients who use clopidogrel to prevent blood clots at risk for heart attacks or strokes if they are also taking omeprazole.

Reports of deaths and serious complications, especially bleeding and infection, associated with NPWT.

Weight loss product contains undeclared drug ingredients sibutramine and phenolphthalein.

Reports of chondrolysis in patients given continuous intra-articular infusions of local anesthetics with elastomeric infusion devices.

Foreign particle contamination of several products manufactured by Genzyme, which may lead to serious adverse events including damage to blood vessels or embolic events, and anaphylactic, allergic and immune-mediated reactions.